Percutaneous penetration of topically applied melatonin in a cream and an alcoholic solution

被引:34
作者
Fischer, TW [1 ]
Greif, C [1 ]
Fluhr, JW [1 ]
Wigger-Alberti, W [1 ]
Elsner, P [1 ]
机构
[1] Univ Jena, Dept Dermatol & Allergol, DE-07740 Jena, Germany
关键词
melatonin; penetration; percutaneous; topical application; serum levels;
D O I
10.1159/000078822
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
In a clinical study, the skin penetration properties of melatonin 0.01% in a cream and 0.01 and 0.03% in a solution were investigated by evaluation of the serum melatonin levels over a 24-hour time course in 15 healthy volunteers. Blood samples for melatonin measurements were taken at 9.00 a. m. before applying the test preparations and 1, 4, 8 and 24 h after application. The measurements were carried out by radioimmunoassay for melatonin. In 15 volunteers, the serum levels of melatonin before application of the topical preparations were between 0.6 and 15.9 pg/ml. After application of the 0.01% melatonin cream, there was a steady increase starting from 9.00 a. m. up to a mean serum value of 9.0 pg/ml at 9.00 a. m. the next day. The solution of 0.01% melatonin also showed an increase, starting from 5.00 p. m., up to a mean melatonin level of 12.7 pg/ml 24 h after application. The solution containing 0.03% melatonin resulted in elevated melatonin levels 1 and 8 h after application. The values were 18.1 and 19.0 pg/ml. The cumulative melatonin values for each preparation were 7.1, 8.6 and 15.7 pg/ml, respectively. This study shows that the strongly lipophilic substance melatonin is able to penetrate through the skin and leads to dose- and galenic-dependent melatonin levels in the blood. No increase of melatonin above the physiological range was observed. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:190 / 194
页数:5
相关论文
共 20 条
[1]  
[Anonymous], BIOL RHYTHMS CLIN LA
[2]   Suppression of UV-induced erythema by topical treatment with melatonin (N-acetyl-5-methoxytryptamine). A dose response study [J].
Bangha, E ;
Elsner, P ;
Kistler, GS .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 1996, 288 (09) :522-526
[3]  
Bangha E, 1997, SKIN PHARMACOL, V10, P298
[4]   Transmucosal, oral controlled-release, and transdermal drug administration in human subjects: A crossover study with melatonin [J].
Benes, L ;
Claustrat, B ;
Horriere, F ;
Geoffriau, M ;
Konsil, J ;
Parrott, KA ;
DeGrande, G ;
McQuinn, RL ;
Ayres, JW .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (10) :1115-1119
[5]   Topical melatonin in combination with vitamins E and C protects skin from ultraviolet-induced erythema:: a human study in vivo [J].
Dreher, F ;
Gabard, B ;
Schwindt, DA ;
Maibach, HI .
BRITISH JOURNAL OF DERMATOLOGY, 1998, 139 (02) :332-339
[6]  
Fischer T, 1999, BIOL SIGNAL RECEPT, V8, P132
[7]   Effect of fatty acids on the permeation of melatonin across rat and pig skin in-vitro and on the transepidermal water loss in rats in-vivo [J].
Kandimalla, K ;
Kanikkannan, N ;
Andega, S ;
Singh, M .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1999, 51 (07) :783-790
[8]   Effect of vehicles on the transdermal delivery of melatonin across porcine skin in vitro [J].
Kikwai, L ;
Kanikkannan, N ;
Babu, RJ ;
Singh, M .
JOURNAL OF CONTROLLED RELEASE, 2002, 83 (02) :307-311
[9]   PHARMACOKINETICS OF MELATONIN IN MAN - 1ST PASS HEPATIC-METABOLISM [J].
LANE, EA ;
MOSS, HB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 61 (06) :1214-1216
[10]  
LEE BJ, 1994, RES COMMUN MOL PATH, V85, P337